FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078136 [Registered on: 16/12/2024] Trial Registered Prospectively
Last Modified On: 15/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect Of Shatayashti Ghrita Aschyotana i.e Shatavari,Yashtimadhu ,Goghrita In Comparison With Carboxymethylcellulose 0.5 percent Eyedrops In The Treatment Of Dry Eye Syndrome W.S.R To Shushkakshipaka 
Scientific Title of Study   Effect of Shatayashti Ghrita Aschyotana in comparison with Carboxymethylcellulose 0.5 percent eyedrop in the treatment of Dry Eye Syndrome w.s.r. to Shushkakshipaka in Adults: A Randomized Controlled Trial 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rakshanda Satish Akre  
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya Nagpur  
Address  OPD NO 11 Shalakya tantra department Pakwasa Rugnalaya Shri Ayurved Mahavidyalaya Dhanwantari Marg Hanuman Nagar Nagpur 440024 Maharashtra India

Nagpur
MAHARASHTRA
440024
India 
Phone  7397840908  
Fax    
Email  rakshandaakre@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ankita Tripathi  
Designation  Assistant professor  
Affiliation  Shri Ayurved Mahavidyalaya Nagpur  
Address  OPD NO 11 Shalakya tantra department Pakwasa Rugnalaya Shri Ayurved Mahavidyalaya Dhanwantari Marg Hanuman Nagar Nagpur 440024 Maharashtra India

Nagpur
MAHARASHTRA
440024
India 
Phone  9130093927  
Fax    
Email  ankitaotripathi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rakshanda Satish Akre  
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya Nagpur  
Address  OPD NO 11 Shalakya tantra department Pakwasa Rugnalaya Shri Ayurved Mahavidyalaya Dhanwantari Marg Hanuman Nagar Nagpur 440024 Maharashtra India

Nagpur
MAHARASHTRA
440024
India 
Phone  7397840908  
Fax    
Email  rakshandaakre@gmail.com  
 
Source of Monetary or Material Support  
OPD NO 11 Shalakya tantra department Pakwasa Rugnalaya Shri Ayurved Mahavidyalaya Dhanwantari Marg Hanuman Nagar Nagpur 440024 Maharashtra India 
 
Primary Sponsor  
Name  Dr Rakshanda Satish Akre  
Address  OPD NO 11 Shalakya tantra department Pakwasa Rugnalaya Shri Ayurved Mahavidyalaya Dhanwantari Marg Hanuman Nagar Nagpur 440024 Maharashtra India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rakshanda Satish Akre   Shri Ayurved Mahavidyalaya Nagpur   OPD NO 11 Shalakya tantra department Pakwasa Rugnalaya Shri Ayurved Mahavidyalaya Dhanwantari Marg Hanuman Nagar Nagpur 440024 Maharashtra India
Nagpur
MAHARASHTRA 
7397840908

rakshandaakre@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethical committee of Shri Ayurved Mahavidyalaya Nagpur   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H045||Stenosis and insufficiency of lacrimal passages. Ayurveda Condition: SUSHKAKSHIPAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: SHATAYASHTI GHRITA ASCHYOTANA , Reference: Yogratnakara , Bhaishajya ratnavali,sharangdhar samhita, Route: Ocular, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 2(drops), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)DrugOther than Classical(1) Medicine Name: Carboxymethyl cellulose 0.5% eye drop, Reference: NA, Route: Ocular, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 2(drops), Frequency: tds, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
3Comparator Arm (Non Ayurveda)Drug-
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient having signs & symptoms of digital eye strain.
Patient with Computer vision syndrome.
Patient having age group of 16-50 years irrespective of their sex, caste , economical status & residence status.
Patient willing for treatment.
Patients having normal vision with or without spectacles. 
 
ExclusionCriteria 
Details  Patients not willing for clinical trial.
( Patients suffering from other systemic disorders.
( Patient undergone any intra ocular & extra ocular surgeries.
( Patient having any ocular infectious / inflammatory disorders. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of Shatayashti Ghrita Aschyotana and Carboxymethylcellulose 0.5% eye drop in the treatment of Dry Eye Syndrome.
 
30 days
 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the effect of Shatayashti Ghrita Aschyotana in the treatment of Computer Vision Syndrome  At the end of 30 days 
 
Target Sample Size   Total Sample Size="68"
Sample Size from India="68" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   26/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A consecutive samples of 68 patients who are seeking treatment and care at the study hospital, who fulfil the eligibility (inclusion and exclusion) criteria and who consent to participant will be selected by convenience sampling method from the study setting (ie. the OPD/Ward/Hospital..). The sample will be then randomly and equally allocated to two groups.
The selected sample of 68 subjects will be randomly allocated to two
groups using Simple block randomization method. A predetermined,
computer generated random allocation plan will be utilised where in 17 blocks of size 4 each will be used for equal assignment of subjects in to two comparison groups.First group will recieve Shatayashti GHRITA ASCHYOTANA and second group will recieve CMC EYEDROP.
 
Close